FULCRUM THERAPEUTICS, INC. Other Comprehensive Income (Loss), Net of Tax
FULCRUM THERAPEUTICS, INC. (FULC) reported Other Comprehensive Income (Loss), Net of Tax of -$54.00 thousand for the 3-month period ending 2026-06-30, per its S-4 filed 2026-09-02.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTax · last filed 2026-09-02
- FULCRUM THERAPEUTICS, INC. other comprehensive income (loss), net of tax for the quarter ending 2026-06-30 was -$54.00K, a 550.00% decline year-over-year.
- FULCRUM THERAPEUTICS, INC. other comprehensive income (loss), net of tax for the quarter ending 2026-03-31 was -$687.00K.
- FULCRUM THERAPEUTICS, INC. other comprehensive income (loss), net of tax for the quarter ending 2025-12-31 was -$67.00K.
- FULCRUM THERAPEUTICS, INC. other comprehensive income (loss), net of tax for the quarter ending 2025-09-30 was $159.00K, a 78.66% decline year-over-year.
- FULCRUM THERAPEUTICS, INC. other comprehensive income (loss), net of tax for fiscal 2023 was $661.00K.
- FULCRUM THERAPEUTICS, INC. other comprehensive income (loss), net of tax for fiscal 2022 was -$400.00K.
- FULCRUM THERAPEUTICS, INC. other comprehensive income (loss), net of tax for fiscal 2021 was -$395.00K.
- FULCRUM THERAPEUTICS, INC. other comprehensive income (loss), net of tax for fiscal 2020 was -$2.00K.
| Period end | Other Comprehensive Income (Loss), Net of Tax 3 month | Other Comprehensive Income (Loss), Net of Tax 3 month as first filed | Other Comprehensive Income (Loss), Net of Tax 6 month | Other Comprehensive Income (Loss), Net of Tax 9 month | Other Comprehensive Income (Loss), Net of Tax 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | -$54.00K S-4 · filed 2026-09-02 | -$741.00K S-4 · filed 2026-09-02 | -$808.00K derived: sum of 3 quarters · filed 2026-09-02 | -$649.00K derived: sum of 4 quarters · filed 2026-09-02 | |
| 2026-03-31 | -$687.00K 10-Q · filed 2026-04-27 | -$754.00K derived: sum of 2 quarters · filed 2026-09-02 | -$595.00K derived: sum of 3 quarters · filed 2026-09-02 | -$583.00K derived: sum of 4 quarters · filed 2026-09-02 | |
| 2025-12-31 | -$67.00K derived: S-4 12 month − 10-Q 9 month · filed 2026-09-02 | $92.00K derived: sum of 2 quarters · filed 2026-09-02 | $104.00K derived: sum of 3 quarters · filed 2026-09-02 | $44.00K S-4 · filed 2026-09-02 | |
| 2025-09-30 | $159.00K 10-Q · filed 2025-10-29 | $171.00K derived: sum of 2 quarters · filed 2026-09-02 | $111.00K 10-Q · filed 2025-10-29 | -$138.00K derived: sum of 4 quarters · filed 2026-09-02 | |
| 2025-06-30 | $12.00K S-4 · filed 2026-09-02 | -$48.00K S-4 · filed 2026-09-02 | -$297.00K derived: sum of 3 quarters · filed 2026-09-02 | $448.00K derived: sum of 4 quarters · filed 2026-09-02 | |
| 2025-03-31 | -$60.00K 10-Q · filed 2026-04-27 | -$309.00K derived: sum of 2 quarters · filed 2026-09-02 | $436.00K derived: sum of 3 quarters · filed 2026-09-02 | $504.00K derived: sum of 4 quarters · filed 2026-09-02 | |
| 2024-12-31 | -$249.00K derived: S-4 12 month − 10-Q 9 month · filed 2026-09-02 | $496.00K derived: sum of 2 quarters · filed 2026-09-02 | $564.00K derived: sum of 3 quarters · filed 2026-09-02 | $266.00K S-4 · filed 2026-09-02 | |
| 2024-09-30 | $745.00K 10-Q · filed 2025-10-29 | $813.00K derived: sum of 2 quarters · filed 2025-10-29 | $515.00K 10-Q · filed 2025-10-29 | $1.26M derived: sum of 4 quarters · filed 2025-10-29 | |
| 2024-06-30 | $68.00K 10-Q · filed 2025-07-29 | -$230.00K 10-Q · filed 2025-07-29 | $520.00K derived: sum of 3 quarters · filed 2025-07-29 | $834.00K derived: sum of 4 quarters · filed 2025-07-29 | |
| 2024-03-31 | -$298.00K 10-Q · filed 2025-05-01 | $452.00K derived: sum of 2 quarters · filed 2025-05-01 | $766.00K derived: sum of 3 quarters · filed 2025-05-01 | $217.00K derived: sum of 4 quarters · filed 2025-05-01 | |
| 2023-12-31 | $750.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $1.06M derived: sum of 2 quarters · filed 2025-02-25 | $515.00K derived: sum of 3 quarters · filed 2025-02-25 | $661.00K 10-K · filed 2025-02-25 | |
| 2023-09-30 | $314.00K 10-Q · filed 2024-11-13 | -$314.00K 10-Q · filed 2023-11-07 | -$235.00K derived: sum of 2 quarters · filed 2024-11-13 | -$89.00K 10-Q · filed 2024-11-13 | $35.00K derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | -$549.00K 10-Q · filed 2024-07-31 | -$403.00K 10-Q · filed 2024-07-31 | -$279.00K derived: sum of 3 quarters · filed 2024-07-31 | -$132.00K derived: sum of 4 quarters · filed 2024-07-31 | |
| 2023-03-31 | $146.00K 10-Q · filed 2024-05-13 | $270.00K derived: sum of 2 quarters · filed 2024-05-13 | $417.00K derived: sum of 3 quarters · filed 2024-05-13 | $439.00K derived: sum of 4 quarters · filed 2024-05-13 | |
| 2022-12-31 | $124.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $271.00K derived: sum of 2 quarters · filed 2024-02-27 | $293.00K derived: sum of 3 quarters · filed 2024-02-27 | -$400.00K 10-K · filed 2024-02-27 | |
| 2022-09-30 | $147.00K 10-Q · filed 2023-11-07 | $169.00K derived: sum of 2 quarters · filed 2023-11-07 | -$524.00K 10-Q · filed 2023-11-07 | -$834.00K derived: sum of 4 quarters · filed 2023-11-07 | |
| 2022-06-30 | $22.00K 10-Q · filed 2023-08-03 | -$671.00K 10-Q · filed 2023-08-03 | -$981.00K derived: sum of 3 quarters · filed 2023-08-03 | -$1.06M derived: sum of 4 quarters · filed 2023-08-03 | |
| 2022-03-31 | -$693.00K 10-Q · filed 2023-05-15 | -$1.00M derived: sum of 2 quarters · filed 2023-06-26 | -$1.08M derived: sum of 3 quarters · filed 2023-06-26 | -$1.09M derived: sum of 4 quarters · filed 2023-06-26 | |
| 2021-12-31 | -$310.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-06-26 | -$388.00K derived: sum of 2 quarters · filed 2023-06-26 | -$393.00K derived: sum of 3 quarters · filed 2023-06-26 | -$395.00K 10-K/A · filed 2023-06-26 | |
| 2021-09-30 | -$78.00K 10-Q · filed 2022-11-08 | -$83.00K derived: sum of 2 quarters · filed 2022-11-08 | -$85.00K 10-Q · filed 2022-11-08 | -$118.00K derived: sum of 4 quarters · filed 2023-06-26 | |
| 2021-06-30 | -$5.00K 10-Q · filed 2022-08-11 | -$7.00K 10-Q · filed 2022-08-11 | -$40.00K derived: sum of 3 quarters · filed 2023-06-26 | -$90.00K derived: sum of 4 quarters · filed 2023-06-26 | |
| 2021-03-31 | -$2.00K 10-Q · filed 2022-05-09 | -$35.00K derived: sum of 2 quarters · filed 2023-06-26 | -$85.00K derived: sum of 3 quarters · filed 2023-06-26 | $49.00K derived: sum of 4 quarters · filed 2023-06-26 | |
| 2020-12-31 | -$33.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-06-26 | -$83.00K derived: sum of 2 quarters · filed 2023-06-26 | $51.00K derived: sum of 3 quarters · filed 2023-06-26 | -$2.00K 10-K/A · filed 2023-06-26 | |
| 2020-09-30 | -$50.00K 10-Q · filed 2021-11-04 | $84.00K derived: sum of 2 quarters · filed 2021-11-04 | $31.00K 10-Q · filed 2021-11-04 | ||
| 2020-06-30 | $134.00K 10-Q · filed 2021-08-10 | $81.00K 10-Q · filed 2021-08-10 | |||
| 2020-03-31 | -$53.00K 10-Q · filed 2021-05-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Mereo BioPharma Group plc (MREO) | $0.269B | -9.41 | |
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |